Regulation by Protein Kinase C of Platelet-Activating Factor- and Thapsigargin-Induced Calcium Entry in Rabbit Neutrophils.
スポンサーリンク
概要
- 論文の詳細を見る
12-<I>O</I>-Tetradecanoylphorbol-13-acetate (TPA) time-dependently inhibited the platelet-activating factor (PAF)-induced rise in cytosolic free calcium concentration ([Ca<SUP>2+</SUP>]<SUB>i</SUB>) in rabbit neutrophils, whereas staurosporine significantly enhanced it. Inositol 1, 4, 5-trisphosphate (IP<SUB>3</SUB>) induced Ca<SUP>2+</SUP> release in digitonin-permeabilized cells but not in PAF-pretreated permeabilized cells. IP<SUB>3</SUB>-induced Ca<SUP>2+</SUP> release was not affected by protein kinase C activators or inhibitors. In the cells pretreated with PAF and thapsigargin in Ca<SUP>2+</SUP>-deficient medium, stimulated Ca<SUP>2+</SUP> entry was evoked by the subsequent addition of CaCl<SUB>2</SUB>. TPA inhibited the Ca<SUP>2+</SUP> entry induced by PAF and thapsigargin in a staurosporine-reversible manner but not thapsigargin-induced [Ca<SUP>2+</SUP>]<SUB>i</SUB> elevation. These results suggest that protein kinase C negatively regulates PAF- and thapsigargin-induced rise in [Ca<SUP>2+</SUP>]<SUB>i</SUB> possibly by inhibiting Ca<SUP>2+</SUP> store depletion-induced Ca<SUP>2+</SUP> entry.
- 公益社団法人 日本薬理学会の論文
著者
-
Morita Katsuya
Department Of Dental Pharmacology Hiroshima University Graduate School Of Biomedical Sciences
-
Kitayama Shigeo
Department Of Dental Pharmacology
-
Shibata Kazuyuki
Department Of Biology School Of Education Waseda University
-
Okamoto Hiroshi
Department Of Advanced Biological Sciences For Regeneration (kotobiken Medical Laboratories) Tohoku
-
MORITA Katsuya
Department of Pharmacology, Hiroshima University School of Dentistry
-
Dohi Toshihiro
Department of Dental Pharmacology, Division of Integrated Medical Science, Hiroshima University Graduate School of Biomedical Sciences, Japan
-
Shirakawa Masaharu
Department of Endodontology and Periodontology, Hiroshima University School of Dentistry
関連論文
- 1 Pharmacogenomics of β-blocker Therapy in Chronic Heart Failure(New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Which is most Beneficial for Preserving Cardiac Function and Coronary Microvasculaturein DCM, ACE-I, ARB or Two in Combination? (Cardiac Hypertrophy/Cardiomyopathy 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Eplerenone Prevents Cardiac Fibrosis through the Inhibition of OPN Expression (Cardiac Hypertrophy, Basic (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Osteopontin is Essential for Angiotensin II-Induced Cardiac Fibrosis(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin β_1 Expression
- Angiogenesis Is Altered by Angiotensin Type 1 Receptor Blockade in Cardiomyopathic Hamster Hearts
- Angiotensin II Type 2 Receptor Expression Affects Remodeling after Myocardial Infarction in Mice
- Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
- Blockade of T-cell costimulatory signals using adenovirus vectors attenuates experimental autoimmune myocarditis through the induction of antigen-specific T-cell anergy
- The Chronic Effect of Amlodipine on Cardiac Remodeling in Cardiomyopathic Hamster Hearts